Indications, methodology, and classification of results of tilt-table testing (Q33145112)

22 July 2017

1 reference

title

Indications, methodology, and classification of results of tilt-table testing (English)

1 reference

22 July 2017

0 references

Sutton R

1

1 reference

22 July 2017

Bloomfield DM

series ordinal

2

1 reference

22 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

American Journal of Cardiology

22 July 2017

published in

1 reference

22 July 2017

volume

84

1 reference

22 July 2017

issue

8A

1 reference

22 July 2017

page(s)

10Q-19Q

1 reference

Tilt table testing for assessing syncope. American College of Cardiology

22 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

Tilting towards a diagnosis in recurrent unexplained syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

Tilt Table Testing for Evaluation of Neurally-Mediated (Cardioneurogenic) Syncope: Rationale and Proposed Protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

Changes in plasma epinephrine concentration and in heart rate during head-up tilt testing in patients with neurocardiogenic syncope: correlation with successful therapy with beta-receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

Methodology of head-up tilt testing in patients with unexplained syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

Effects of age on outcome of tilt-table testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

The normal response to prolonged passive head up tilt testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

Usefulness of tilt test-induced patterns of heart rate and blood pressure using a two-stage protocol with glyceryl trinitrate provocation in patients with syncope of unknown origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

Clinical disorders of the autonomic nervous system associated with orthostatic intolerance: an overview of classification, clinical evaluation, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

Neurally mediated syncopal syndromes: pathophysiological concepts and clinical evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

The economics of treating vasovagal syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

The postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during head-up tilt table testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

Putting it together: a new treatment algorithm for vasovagal syncope and related disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

Head-up tilt: a useful test for investigating unexplained syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900692-X

10.1016/S0002-9149(99)00692-X

7 January 2021

Identifiers

DOI

1 reference

22 July 2017

1 reference